Isoflurane Exposure for Three Hours Triggers Apoptotic Cell Death in Neonatal Macaque Brain
Overview
Authors
Affiliations
Background: Retrospective clinical studies suggest there is a risk for neurodevelopmental impairment following early childhood exposure to anaesthesia. In the developing animal brain, including those of non-human primates (NHPs), anaesthetics induce apoptotic cell death. We previously reported that a 5 h isoflurane (ISO) exposure in infant NHPs increases apoptosis 13-fold compared with control animals. However, the majority of paediatric surgeries requiring anaesthesia are of shorter durations. We examined whether 3 h ISO exposure similarly increases neuroapoptosis in the NHP developing brain.
Methods: Six-day-old NHP infants ( Macaca mulatta ) were exposed to 3 h of a surgical plane of ISO ( n =6) or to room air ( n =5). Following exposure, NHP brains were screened for neuronal and oligodendrocyte apoptosis using activated caspase-3 immunolabelling and unbiased stereology.
Results: ISO treatment increased apoptosis (neurones + oligodendrocyte) to greater than four times that in the control group [mean density of apoptotic profiles: 57 (SD 22) mm -3 vs 14 (SD 5.2) mm -3 , respectively]. Oligodendrocyte apoptosis was evenly distributed throughout the white matter whereas neuroapoptosis occurred primarily in the cortex (all regions), caudate, putamen and thalamus.
Conclusions: A 3 h exposure to ISO is sufficient to induce widespread neurotoxicity in the developing primate brain. These results are relevant for clinical medicine, as many surgical and diagnostic procedures in children require anaesthesia durations similar to those modelled here. Further research is necessary to identify long-term neurobehavioural consequences of 3 h ISO exposure.
Pre-clinical and clinical trials for anesthesia in neonates: gaps and future directions.
Barton K, Yellowman R, Holm T, Beaulieu F, Zuckerberg G, Gwal K Pediatr Radiol. 2024; 54(13):2143-2156.
PMID: 39349661 DOI: 10.1007/s00247-024-06066-5.
Puthillathu N, Moffett J, Korotcov A, Bosomtwi A, Vengilote R, Krishnan J Front Pharmacol. 2024; 14:1293280.
PMID: 38230376 PMC: 10790757. DOI: 10.3389/fphar.2023.1293280.
Kim J, Barcus R, Lipford M, Yuan H, Ririe D, Jung Y Cereb Cortex. 2023; 34(1).
PMID: 38142289 PMC: 10793576. DOI: 10.1093/cercor/bhad463.
Neudecker V, Perez-Zoghbi J, Miranda-Dominguez O, Schenning K, Ramirez J, Mitchell A Br J Anaesth. 2023; 131(6):1030-1042.
PMID: 37714750 PMC: 10687619. DOI: 10.1016/j.bja.2023.07.031.
Areias J, Sola C, Chastagnier Y, Pico J, Bouquier N, Dadure C Sci Rep. 2023; 13(1):14763.
PMID: 37679476 PMC: 10484929. DOI: 10.1038/s41598-023-41750-w.